Tamsulosin Hcl
Rank #104 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$168.5M
Total Cost
8,367,036
Total Claims
$168.5M
Total Cost
99,112
Prescribers
$20
Cost per Claim
2,336,243
Beneficiaries
18,650,125
30-Day Fills
$1,700
Avg Cost/Provider
84
Avg Claims/Provider
Share of Medicare Part D Spending
0.06%
of total Medicare Part D spending
$168.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $168.5M total
Top Prescribers of Tamsulosin Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Igor Ryndin | Urology | Brooklyn, NY | 4,208 | $158K |
| 2 | Glenn Kershen | Urology | Saginaw, MI | 3,677 | $127K |
| 3 | Armen Kassabian | Urology | Burbank, CA | 4,338 | $102K |
| 4 | Nancy Wilcox | Nurse Practitioner | Rochester, NY | 4,276 | $94K |
| 5 | Leonard Renfer | Urology | Salinas, CA | 2,354 | $89K |
| 6 | Natakom Chulamorkodt | Urology | Yuma, AZ | 2,004 | $89K |
| 7 | Luke Yoon | Urology | Los Angeles, CA | 3,504 | $89K |
| 8 | Paul Ceplenski | Urology | New Britain, CT | 2,065 | $65K |
| 9 | Steven Jensen | Urology | Saginaw, MI | 2,661 | $64K |
| 10 | Theodore Affue | Urology | El Centro, CA | 1,482 | $63K |
| 11 | Khoi Tang | Urology | Garden Grove, CA | 2,155 | $61K |
| 12 | Robert Luangkhot | Urology | Flushing, NY | 2,161 | $61K |
| 13 | Marcus Loo | Urology | New York, NY | 2,599 | $60K |
| 14 | Wenwu Jin | Urology | San Francisco, CA | 2,106 | $57K |
| 15 | Jacob Sharaby | Urology | Brooklyn, NY | 1,576 | $56K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 101 | Dolutegravir Sodium/Lamivudine (Dovato) | $173.3M | 56,930 |
| 102 | Potassium Chloride (Klor-Con M20) | $172.6M | 6,137,143 |
| 103 | Darunavir/Cob/Emtri/Tenof Alaf (Symtuza) | $172.5M | 34,812 |
| 104 | Tamsulosin Hcl (Tamsulosin Hcl) | $168.5M | 8,367,036 |
| 105 | Carbidopa/Levodopa (Carbidopa-Levodopa) | $168.3M | 1,361,770 |
| 106 | Duloxetine Hcl (Duloxetine Hcl) | $167.7M | 5,106,690 |
| 107 | Sucroferric Oxyhydroxide (Velphoro) | $166.8M | 54,837 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology